- High-Growth Investing | April 25, 2012
Buy, Sell, or Hold: Sequenom
$1,000 genetic sequencing bodes well for this stock.
- High-Growth Investing | April 20, 2012
This Takeover Is Off the Table. Maybe.
Has Roche walked away from Illumina, or is it bluffing?
- High-Growth Investing | April 13, 2012
It's Time to Start Buying Into the Next Bubble
This revolutionary technology will change the world... and your portfolio.
- Investing | April 12, 2012
You, Sir, Are No Apple (but We Still Want to Buy You)
Roche insults Illumina, Lloyd Bentsen-style.
- Investing | April 09, 2012
2 Stocks That Just Raised the Bar
A bullish market signal and positive CAPS sentiment might make a winning combination.
- Investing | April 03, 2012
Why Bio-Rad Shares Popped
Is this meaningful? Or just another movement?
- High-Growth Investing | March 30, 2012
Gattaca, Here We Come
Complete Genomics can process saliva samples now.
- Investing | March 29, 2012
Sequence This Offer
Roche ups its offer for Illumina; investors want more.
- Investing | March 20, 2012
Is Wall Street Wrong About These Stocks?
You love 'em, analysts are meh -- who's got it right?
- Investing | February 29, 2012
Calling This Buyout Offer Bluff
Roche won't take no for an answer.